References

• 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66(1):7-30. google scholar
• 2. Trewartha D, Carter K. Advances in prostate cancer treatment. Nat Rev Drug Discov 2013; 12(11):823-4. google scholar
• 3. Scher HI, Leibel SA, Fuks Z, Cordon-Cardo C, Scardino PT. Cancers of the prostate. DeVita VT Jr, Hellman S, Rosenberg SA, editors. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. google scholar
• 4. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148(6):435-48. google scholar
• 5. Moe EL, Chadd J, McDonagh M, Valtonen M, Horner-Johnson W, Eden KB, el al. Exercise interventions for prostate cancer survivors receiving hormone therapy: Systematic review. Translational Journal of the ACSM 2017; 2(1):1-9. google scholar
• 6. Botrel TE, Clark O, Lima Pompeo AC, Horta Bretas FF, Sadi MV, Ferreira U, et al. Efficacy and safety of combined androgen deprivation therapy (ADT) and docetaxel compared with ADT alone for metastatic hormone-naive prostate cancer: A systematic review and meta-analysis. PLoS One 2016; 11(6):e0157660. google scholar
• 7. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012; 75(3):311-35. google scholar
• 8. Safe S, Kasiappan R. Natural products as mechanism-based anticancer agents: Sp transcription factors as targets. Phytother Res 2016; 30(11):1723-32. 9. Mancuso C, Santangelo R. Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol 2014; 65:185-95. google scholar
• 10. Ou S, Kwok KC. Ferulic acid: pharmaceutical functions, preparation and applications in foods. J. Sci. Food. Agric 2004; 84:1261-9. google scholar
• 11. Trombino S, Serini S, Di Nicuolo F, Celleno L, Andò S, Picci N, et al. Antioxidant effect of ferulic acid in isolated membranes and intact cells: synergistic interactions with alpha-tocopherol, beta-carotene, and ascorbic acid. J Agric Food Chem 2004; 52(8):2411-20. google scholar
• 12. Borges A, Ferreira C, Saavedra MJ, Simões M. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. Microb Drug Resist 2013; 19(4):256-65. google scholar
• 13. Zhu H, Liang QH, Xiong XG, Chen J, Wu D, Wang Y, et al. Anti-inflammatory effects of the bioactive compound ferulic acid contained in Oldenlandia diffusa on collagen-induced arthritis in rats. Evid Based Complement Alternat Medn 2014; 2014:573801. google scholar
• 14. Hong Q, Ma ZC, Huang H, Wang YG, Tan HL, Xiao CR, et al. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling. Eur J Pharmacol 2016; 777:1-8. google scholar
• 15. Shahidi F, Chandrasekara A. Hydroxycinnamates and their in vitro and in vivo antioxidant activities. Phytochem Rev 2010; 9(1):147–170. google scholar
• 16. Serafim TL, Carvalho FS, Marques MP, Calheiros R, Silva T, Garrido J, et al. Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells. Chem Res Toxicol 2011; 24(5):763-74. google scholar
• 17. Thakkar A, Chenreddy S, Wang J, Prabhu S. Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles. Cell Biosci 2015; 5:46. google scholar
• 18. Eroğlu C, Seçme M, Bağcı G, Dodurga Y. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines. Tumour Biol 2015; 36(12):9437-46. google scholar
• 19. Fong Y, Tang CC, Hu HT, Fang HY, Chen BH, Wu CY, et al. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin Med 2016;11:45. google scholar
• 20. Wang T, Gong X, Jiang R, Li H, Du W, Kuang G. Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K/Akt pathway in osteosarcoma cell. Am J Transl Res 2016; 8(2):968-80. google scholar
• 21. Choi YE, Park E. Ferulic acid in combination with PARP inhibitor sensitizes breast cancer cells as chemotherapeutic strategy. Biochem Biophys Res Commun 2015; 458(3):520-4. google scholar
• 22. Kalimuthu S, Se-Kwon K. Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds. Int J Mol Sci 2013; 14(2):2334-54. google scholar
• 23. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007; 35(4):495-516. google scholar
• 24. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;1 2(20 Pt 2):6243-9. google scholar
• 25. Sturge J, Caley MP, Waxman J. Bone metastasis in prostate cancer: Emerging therapeutic strategies. Nat Rev Clin Oncol 2011;8(6):357-68. google scholar
• 26. Guan X. Cancer metastases: Cehallenges and opportunities. Acta Pharm Sin B 2015; 5(5):402-18. google scholar
• 27. Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, Prince M, et al. Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Semin Cancer Biol 2015; 35:244-75. google scholar
• 28. Wong A, Soo RA, Yong WP, Innocenti F. Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metab Rev 2009; 41(2):77-88. google scholar
• 29. Huang CY, Chang YJ, Luo SD, Uyanga B, Lin FY, Tai CJ, et al. Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer. Tumour Biol 2016; 37(3):4075-82. google scholar
• 30. Di Lorenzo G, Autorino R, Giuliano M, Morelli E, Giordano A, Napodano G, et al. Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer. Urology 2007; 69(2):347-51. google scholar
• 31. Lee JL, Ahn JH, Choi MK, Kim Y, Hong SW, Lee KH, et al. Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed. Br J Cancer 2014; 110(10):2472-8. google scholar
• 32. Reddy L, Odhav B, Bhoola KD. Natural products for cancer prevention: A global perspective. Pharmacol Ther 2003; 99:1–13. google scholar
• 33. Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr 2013; 4(3):384S-92S. google scholar
• 34. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81:317S–25S. google scholar
• 35. Russell W, Duthie G. Plant secondary metabolites and gut health: the case for phenolic acids. Proc Nutr Soc 2011; 70:389–96. google scholar
• 36. Syed DN, Khan N, Afaq F, Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 2007; 16(11):2193-203. google scholar
• 37. Singh CK, George J, Ahmad N.Resveratrol-based combinatorial strategies for cancer management. Ann N Y Acad Sci 2013; 1290:113-21. google scholar
• 38. Anantharaju PG, Gowda PC, Vimalambike MG, Madhunapantula SV. An overview on the role of dietary phenolics for the treatment of cancers. Nutr J 2016; 15(1):99. google scholar
• 39. Chowdhury S, Ghosh S, Rashid K, Sil PC. Deciphering the role of ferulic acid against streptozotocin-induced cellular stress in the cardiac tissue of diabetic rats. Food Chem Toxicol 2016; 97:187-98. google scholar
• 40. Li H, Wang Y, Fan R, Lv H, Sun H, Xie H, et al. The effects of ferulic acid on the pharmacokinetics of warfarin in rats after biliary drainage. Drug Des Devel Ther 2016; 10: 2173–80. google scholar
• 41. Pan Y, Zhao G, Cai Z, Chen F, Xu D, Huang S, et al. Synergistic effect of ferulic acid and Z-Ligustilide, major components of A. sinensis, on regulating cold-sensing protein TRPM8 and TPRA1 in vitro. Evid Based Complement Alternat Med 2016; 2016: 3160247. google scholar
• 42. Li G, Ruan L, Chen R, Wang R, Xie X, Zhang M, et al. Synergistic antidepressant-like effect of ferulic acid in combination with piperine: involvement of monoaminergic system. Metab Brain Dis 2015; 30(6):1505-14. google scholar
• 43. Canturk Z. Evaluation of synergistic anticandidal and apoptotic effects of ferulic acid and caspofungin against Candida albicans. J Food Drug Anal 2017; 1-5. google scholar
• 44. Rahman H, Upaganlawar A, Upasani C. Protective effect of ferulic ccid alone and in combination with ascorbic acid on aniline induced spleen toxicity. Ann Pharmacol Pharm 2017; 2(1): 1012. google scholar
• 45. Eitsuka T, Tatewaki N, Nishida H, Kurata T, Nakagawa K, Miyazawa T. Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid. Biochem Biophys Res Commun 2014;453(3):606-11. google scholar
• 46. Eitsuka T, Tatewaki N, Nishida H, Nakagawa K, Miyazawa T. A Combination of δ-tocotrienol and ferulic acid synergistically inhibits telomerase activity in DLD-1 human colorectal adenocarcinoma cells. J Nutr Sci Vitaminol (Tokyo) 2016; 62(5):281-7. google scholar
• 47. Goldar S, Khaniani MS, Derakhshan SM, Baradaran B. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev 2015; 16(6):2129-44. google scholar
• 48. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119(6):1420-8. google scholar
• 49. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27(20):2192-206. google scholar
• 50. Jacob A, Prekeris R. The regulation of MMP targeting to invadopodia during cancer metastasis. Front Cell Dev Biol 2015;3:4. google scholar

Citations